
Annette Ozaltin
@annetteozaltin
Program Director @Results4Dev
ID: 95652887
http://linkedin.com/in/annettemartin 09-12-2009 14:09:33
60 Tweet
88 Followers
157 Following

🙏Thank you for sharing your expertise Asaf Bitton @chris_m_h cynthia antwi 🇧🇼🇬🇭 Dr Githinji Gitahi, MBS Danielle Bloom Cynthia Eldridge Edward Kelley Faraz Khalid Amanda Glassman Irina A. Nikolic Ikenna Mgbedimma Impact for Health S. Skye Gilbert Steve Davis Timi Omole Tricia Bolender

🙏Thank you for sharing your expertise @jklBanjul Kariane St-Denis @kelsaldana_HSS Meredith Kimball @_LoftyInc_Nigeria Lisa Hirschhorn chris masila Maureen Lewis @moshoodha ng OTRAC @policy_doc Poncelet Ileleji Farida Kabir @salientadvisory @shwetankv Stefan Nachuk www.wellvis.org Peter Waiswa








How can cost studies be used for planning & budgeting- experiences from #Vietnam #Tanzania #Indonesia ThinkWell Immunization Economics Annette Ozaltin Garrett Skrovina ghspjournal.org/content/ghsp/e…

Delighted to share findings from our evidence-to-policy work in Indonesia, Tanzania, and Vietnam. ThinkWell JSI | Better health & education outcomes. For all. Immunization Economics Results for Development Logan Brenzel, PhD Lora Shimp Garrett Skrovina ghspjournal.org/content/ghsp/e…

📣 Just announced: Gavi, the Vaccine Alliance's immunisation learning network for middle-income countries (MICs), called the Linked Immunisation Action Network (Linked) has launched! Learn more about the network at linkedimmunisation.org.


❗ To help MICs identify practical solutions & best practices to mitigate & prevent decreases in immunisation coverage & drive sustainable intro of key missing vaccines, Gavi, the Vaccine Alliance's immunisation learning network for MICs is launching! Learn more at linkedimmunisation.org

R4D's Annette Ozaltin and key collaborator Edward Owino share insights from our health campaign financing landscape analysis, which identifies both financial barriers and opportunities for campaign collaboration, in this set of video presentations. ▶️ bit.ly/3v2HigD


❓How many middle-income countries that transitioned from Gavi support achieved the global target of 90% for DTP3 in 2021? Learn this and other pertinent information on coverage, equity and new vaccine introduction in Linked Immunisation Action Network's country dashboards. ▶️ bit.ly/3PkTwsh


How many middle-income countries that transitioned from Gavi support achieved the global target of 90% for DTP3 in 2021? Learn this & more on coverage, equity, & new vaccine introduction in these country dashboards from Linked Immunisation Action Network, led by R4D & partners. linkedimmunisation.org/resources/link…


📰 Of the 19 countries that transitioned from Gavi support, did you know 8 had 2021 coverage levels over the global 90% target for DTP3 while 11 were below? Learn more in these middle-income country dashboards by Linked Immunisation Action Network, led by R4D and partners. ▶️ bit.ly/3PkTwsh


❓How did Uzbekistan reach greater than 90% first-dose coverage of the HPV vaccine among girls aged 12 to 14? Explore their experiences and lessons learned in Linked Immunisation Action Network's new Practitioner Perspectives interview: bit.ly/3PrITFA


📰 How did Uzbekistan become an exemplary model for HPV vaccine introduction in the European region? Dilorom Tursunova, Head of the EPI, explores the country's strategies and lessons learned in Linked Immunisation Action Network's new Practitioner Perspectives interview: bit.ly/3PrITFA

